In db/db mice, another study by Liu et al. showed that FEX (50 mg/kg for 8 weeks) reduced liver steatosis through the activation of the FXR-SHP-CPT1α signaling pathway [31]. The gene discussed is CPT1A; the disease is Hepatic steatosis.